Bristol-Myers Squibb

YTD

ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.

CEO

Christopher S. Boerner

CEOChristopher S. Boerner

Employees

32,500

Employees32,500

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1933

Founded1933

Employees

32,500

Employees32,500

BMY Key Statistics

Market cap

118.86B

Market cap118.86B

Price-Earnings ratio

16.09

Price-Earnings ratio16.09

Dividend yield

4.36%

Dividend yield4.36%

Average volume

9.80M

Average volume9.80M

High today

$58.64

High today$58.64

Low today

$57.08

Low today$57.08

Open price

$57.39

Open price$57.39

Volume

4.99M

Volume4.99M

52 Week high

$62.89

52 Week high$62.89

52 Week low

$42.52

52 Week low$42.52

Stock Snapshot

Bristol-Myers Squibb(BMY) stock is priced at $58.21, giving the company a market capitalization of 118.86B. It carries a P/E multiple of 16.09 and pays a dividend yield of 4.4%.

During the trading session on 2026-05-19, Bristol-Myers Squibb(BMY) shares reached a daily high of $58.64 and a low of $57.08. At a current price of $58.21, the stock is +2.0% higher than the low and still -0.7% under the high.

Trading activity shows a volume of 4.99M, compared to an average daily volume of 9.8M.

The stock's 52-week range extends from a low of $42.52 to a high of $62.89.

BMY News

TipRanks 3h

Bristol-Myers Squibb’s REACH Study in China: What Real-World Luspatercept Data Could Mean for BMY Investors

Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter,...

Simply Wall St 10h

Bristol Myers Squibb Houston Plant Raises Questions On Value And Outlook

Bristol-Myers Squibb plans to build a new US$1b pharmaceutical manufacturing facility in Houston. The project is expected to create nearly 500 jobs and expand...

Simply Wall St 3d

Is Hengrui’s US$15.2 Billion Alliance Reshaping the Investment Case for Bristol Myers Squibb? - simplywall.st

...

Analyst ratings

58%

of 31 ratings

Buy

38.7%

Hold

58.1%

Sell

3.2%

More BMY News

TipRanks 5d

Bristol-Myers Squibb Advances Navlimetostat With Key Phase 1 Tablet Study

Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter,...

TipRanks 5d

Bristol-Myers Squibb Completes Key Afimetoran–Famotidine Interaction Study: What Investors Should Know

Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter,...

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.